Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1084
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients ; day:30 ; month:11 ; year:2018 ; pages:1-8
European radiology ; (30.11.2018), 1-8

Urheber
Bradley, C.
Scott, R. A.
Cox, E.
Palaniyappan, N.
Thomson, B. J.
Ryder, S. D.
Irving, W. L.
Aithal, G. P.
Guha, I. N.
Francis, S.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00330-018-5788-1
URN
urn:nbn:de:101:1-2019011721220110512825
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:03 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bradley, C.
  • Scott, R. A.
  • Cox, E.
  • Palaniyappan, N.
  • Thomson, B. J.
  • Ryder, S. D.
  • Irving, W. L.
  • Aithal, G. P.
  • Guha, I. N.
  • Francis, S.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Direct-acting antivirals and visceral leishmaniasis: a case report

Direct-acting antivirals and visceral leishmaniasis: a case report

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients

Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

Verbundene Objekte